{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-28T16:39:39.554160+00:00","company":{"ticker":"AIXC","cik":1460702,"company_name":"AIxCrypto Holdings, Inc."},"pagination":{"limit":100,"returned":82,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Alpha Capital Anstalt","detail":"equity_purchase","count":4,"first_seen":"2022-12-22T23:59:59+00:00","last_seen":"2024-02-27T23:59:59+00:00","evidence_fact_ids":[71549,89593,110467,189364]},{"display_name":"GOLD KING ARTHUR HOLDING LIMITED","detail":"other","count":2,"first_seen":"2026-02-02T23:59:59+00:00","last_seen":"2026-06-17T20:30:26+00:00","evidence_fact_ids":[33862,170052]},{"display_name":"GOLD KING ARTHUR HOLDING LIMITED and Song Wang","detail":"other","count":2,"first_seen":"2026-04-16T23:59:59+00:00","last_seen":"2026-04-16T23:59:59+00:00","evidence_fact_ids":[24334,24335]},{"display_name":"CABG ACQUISITION CORP.","detail":"notes_offering","count":1,"first_seen":"2026-05-14T20:31:14+00:00","last_seen":"2026-05-14T20:31:14+00:00","evidence_fact_ids":[102645]},{"display_name":"Chembio Diagnostics, Inc. and Biosynex, S.A.","detail":"asset_purchase","count":1,"first_seen":"2023-07-26T23:59:59+00:00","last_seen":"2023-07-26T23:59:59+00:00","evidence_fact_ids":[127828]},{"display_name":"FF Global Partners LLC","detail":"other","count":1,"first_seen":"2026-02-02T23:59:59+00:00","last_seen":"2026-02-02T23:59:59+00:00","evidence_fact_ids":[33861]},{"display_name":"GOLD KING ARTHUR HOLDING LIMITED and Faraday Future Intelligent Electric Inc.","detail":"equity_purchase","count":1,"first_seen":"2026-04-16T23:59:59+00:00","last_seen":"2026-04-16T23:59:59+00:00","evidence_fact_ids":[24336]},{"display_name":"Nanosynex Ltd.","detail":"settlement","count":1,"first_seen":"2023-07-26T23:59:59+00:00","last_seen":"2023-07-26T23:59:59+00:00","evidence_fact_ids":[127829]},{"display_name":"Pan-RAS Holdings, Inc.","detail":"license","count":1,"first_seen":"2024-03-28T23:59:59+00:00","last_seen":"2024-03-28T23:59:59+00:00","evidence_fact_ids":[64391]}],"lender":[{"display_name":"Alpha Capital Anstalt","detail":"convertible_notes","count":1,"first_seen":"2022-12-22T23:59:59+00:00","last_seen":"2022-12-22T23:59:59+00:00","evidence_fact_ids":[189367]},{"display_name":"Marizyme, Inc.","detail":"loan","count":1,"first_seen":"2025-08-27T23:59:59+00:00","last_seen":"2025-08-27T23:59:59+00:00","evidence_fact_ids":[42294]},{"display_name":"Yi Hua Chen","detail":"convertible_notes","count":1,"first_seen":"2024-04-16T23:59:59+00:00","last_seen":"2024-04-16T23:59:59+00:00","evidence_fact_ids":[61590]}],"ma_counterparty":[{"display_name":"Chembio Diagnostics, Inc.","detail":"disposition","count":1,"first_seen":"2023-07-26T23:59:59+00:00","last_seen":"2023-07-26T23:59:59+00:00","evidence_fact_ids":[127831]}]},"facts":[{"fact_type":"material_agreement","fact_key":"7ebd4cb558adddaf20958c5d3c4633c5e791bc27","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-06-17T20:30:26+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Gold King Arthur Holding Limited","effective_date":"2026-06-16","item_codes_triggered":["1.01"],"value_text":"$50,000,000"},"claim":"AIxCrypto Holdings, Inc. entered into Purchase Agreement with Gold King Arthur Holding Limited valued at $50,000,000 (effective 2026-06-16).","evidence_excerpt":"On June 16, 2026, AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”) entered into a common shares purchase agreement (the “Purchase Agreement”) with Gold King Arthur Holding Limited, a Hong Kong limited liability company (the “Purchaser”) pursuant to which the Company agreed to sell and issue to the Purchaser in a private placement offering (the “Offering”) up to the lesser of (i) $50,000,000 in aggregate gross purchase price of duly authorized, validly issued, fully paid and non-assessable shares of common stock of the Company, par value $0.001 per share (the “Common Shares”) and (ii) 19.99% of the voting power of the Common Shares issued and outstanding immediately prior to the execution of the Purchase Agreement (the “Exchange Cap”), as adjusted pursuant to the terms of the Purchase Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-029096","anchor_url":"https://secwatch.observer/filing/0001493152-26-029096#claim-7ebd4cb558adddaf20958c5d3c4633c5e791bc27","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226029096/0001493152-26-029096-index.htm"},{"fact_type":"executive_change","fact_key":"e37598002c","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-21","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jerry Wang was appointed as director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 21, 2026, the Board appointed Jerry Wang to serve as a director of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-e37598002c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"19f675813e","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-21","interim":false,"role":"President and Chief Financial Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jie (Jay) Sheng was appointed as President and Chief Financial Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 21, 2026, the Board appointed Jie (Jay) Sheng, current independent director of the Company, as President, and as Chief Financial Officer, effective June 21, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-19f675813e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"718e51f44b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-05-21","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Campbell Becher resigned as President at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 21, 2026, Campbell Becher resigned from his position as President of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-718e51f44b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"59dded6638","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-05-21","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Koti Meka resigned as director at AIxCrypto Holdings, Inc..","evidence_excerpt":"Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-59dded6638","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"7ed9464398","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-06-20","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Jie (Jay) Sheng","successor_named":true},"claim":"Koti Meka resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-7ed9464398","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"94c9149689","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-05-21","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kevin Richardson II resigned as director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the \"Company\") board of directors (the \"Board\") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-94c9149689","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"executive_change","fact_key":"414a3996d1","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-28T21:23:37+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-05-21","interim":false,"role":"Co-Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Kevin Richardson II resigned as Co-Chief Executive Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the \"Company\") board of directors (the \"Board\") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025670","anchor_url":"https://secwatch.observer/filing/0001493152-26-025670#claim-414a3996d1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226025670/0001493152-26-025670-index.htm"},{"fact_type":"material_agreement","fact_key":"0652f3931a30350c9f0e013e3fff66c2d7815176","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-05-14T20:31:14+00:00","payload":{"action":"entry","agreement_name":"Note Purchase Agreement","agreement_type":"notes_offering","counterparty":"CABG ACQUISITION CORP.","effective_date":"2026-05-12","item_codes_triggered":["1.01"],"value_text":"$100,000"},"claim":"AIxCrypto Holdings, Inc. entered into Note Purchase Agreement with CABG ACQUISITION CORP. valued at $100,000 (effective 2026-05-12).","evidence_excerpt":"On May 12, 2026, the AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with CABG ACQUISITION CORP. (“Buyer”), pursuant to which the Company agreed to sell, assign, and transfer to the Buyer, all of the Company’s right, title, and interest in the Note Package","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-023124","anchor_url":"https://secwatch.observer/filing/0001493152-26-023124#claim-0652f3931a30350c9f0e013e3fff66c2d7815176","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226023124/0001493152-26-023124-index.htm"},{"fact_type":"material_agreement","fact_key":"0f85f87b1a194af727764467fb87510ad0c86e78","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-04-16T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended and Restated Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"GOLD KING ARTHUR HOLDING LIMITED and Faraday Future Intelligent Electric Inc.","effective_date":"2026-04-14","item_codes_triggered":["1.01"],"value_text":"$12 million"},"claim":"AIxCrypto Holdings, Inc. amended Amended and Restated Securities Purchase Agreement with GOLD KING ARTHUR HOLDING LIMITED and Faraday Future Intelligent Electric Inc. valued at $12 million (effective 2026-04-14).","evidence_excerpt":"On April 14, 2026 (the \"Signing Date\"), GKA and FFAI entered into an Amended and Restated Securities Purchase Agreement (the \"A&R Purchase Agreement\"","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-017084","anchor_url":"https://secwatch.observer/filing/0001493152-26-017084#claim-0f85f87b1a194af727764467fb87510ad0c86e78","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226017084/0001493152-26-017084-index.htm"},{"fact_type":"material_agreement","fact_key":"6db0b2638653afb03e07f02833f9b3107cd34f13","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-04-16T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Second Entrustment Investment Amendment Agreement","agreement_type":"other","counterparty":"GOLD KING ARTHUR HOLDING LIMITED and Song Wang","effective_date":"2026-04-10","item_codes_triggered":["1.01"],"value_text":null},"claim":"AIxCrypto Holdings, Inc. amended Second Entrustment Investment Amendment Agreement with GOLD KING ARTHUR HOLDING LIMITED and Song Wang (effective 2026-04-10).","evidence_excerpt":"the Company further entered into the second amendment to the entrusted agreement (the \"Second Entrustment Investment Amendment Agreement\")","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-017084","anchor_url":"https://secwatch.observer/filing/0001493152-26-017084#claim-6db0b2638653afb03e07f02833f9b3107cd34f13","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226017084/0001493152-26-017084-index.htm"},{"fact_type":"material_agreement","fact_key":"d30445a35deccf2b82ddec86fcb8c9daaaf96cf3","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-04-16T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"First Entrusted Investment Amendment Agreement","agreement_type":"other","counterparty":"GOLD KING ARTHUR HOLDING LIMITED and Song Wang","effective_date":"2026-04-10","item_codes_triggered":["1.01"],"value_text":null},"claim":"AIxCrypto Holdings, Inc. amended First Entrusted Investment Amendment Agreement with GOLD KING ARTHUR HOLDING LIMITED and Song Wang (effective 2026-04-10).","evidence_excerpt":"On April 10, 2026, the Company, GKA, and Song entered into the first amendment to the entrusted investment agreement (the \"First Entrusted Investment Amendment Agreement\")","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-017084","anchor_url":"https://secwatch.observer/filing/0001493152-26-017084#claim-d30445a35deccf2b82ddec86fcb8c9daaaf96cf3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226017084/0001493152-26-017084-index.htm"},{"fact_type":"earnings_release","fact_key":"9fbadecb0c7b71af82b958900efd4cd4ceb5da98","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-03-27T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fiscal year ended December 31, 2025","report_date":"2026-03-24","result_type":"reported_results","revenue_text":null},"claim":"AIxCrypto Holdings, Inc. reported financial results for the fiscal year ended December 31, 2025.","evidence_excerpt":"On March 24, 2026, the Company issued a press release announcing its financial and operational results for the fiscal year ended December 31, 2025, and an investor webcast that occurred on March 24, 2026 to discuss such results and update shareholders on general corporate developments.","confidence":0.7,"filing_url":"https://secwatch.observer/filing/0001493152-26-013224","anchor_url":"https://secwatch.observer/filing/0001493152-26-013224#claim-9fbadecb0c7b71af82b958900efd4cd4ceb5da98","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226013224/0001493152-26-013224-index.htm"},{"fact_type":"material_agreement","fact_key":"50759396f02b1dd0c45666595d9a3cff37c31a90","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-02-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Entrusted Investment Agreement","agreement_type":"other","counterparty":"GOLD KING ARTHUR HOLDING LIMITED","effective_date":"2026-01-30","item_codes_triggered":["1.01"],"value_text":"aggregate consideration of $10,000,000"},"claim":"AIxCrypto Holdings, Inc. entered into Entrusted Investment Agreement with GOLD KING ARTHUR HOLDING LIMITED valued at aggregate consideration of $10,000,000 (effective 2026-01-30).","evidence_excerpt":"On January 30, 2026, the Company entered into an entrusted investment agreement (the “Entrusted Investment Agreement”) with GOLD KING ARTHUR HOLDING LIMITED (“GKA”) and Song Wang (“Song\"), under which the Company entrusted to GKA to manage an investment of shares (\"FFAI Shares\") of Class A common stock, par value $0.0001 per share (\"FFAI Class A Common Stock\"), of Faraday Future Intelligent Electric Inc. (\"FFAI\"), a Delaware corporation with its FFAI Class A Common Stock traded on The Nasdaq Stock Market LLC (\"Nasdaq\").","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-004774","anchor_url":"https://secwatch.observer/filing/0001493152-26-004774#claim-50759396f02b1dd0c45666595d9a3cff37c31a90","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226004774/0001493152-26-004774-index.htm"},{"fact_type":"material_agreement","fact_key":"63bd893fad5fd52b50ac23ef8378a88b1b92b7a7","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2026-02-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Consulting Agreement","agreement_type":"other","counterparty":"FF Global Partners LLC","effective_date":"2025-11-01","item_codes_triggered":["1.01"],"value_text":"$100,000 per month"},"claim":"AIxCrypto Holdings, Inc. entered into Consulting Agreement with FF Global Partners LLC valued at $100,000 per month (effective 2025-11-01).","evidence_excerpt":"On January 28, 2026, AIxCrypto Holdings, Inc. (the “Company”) entered into a consulting services agreement (the “Consulting Agreement”), effective as of November 1, 2025, with FF Global Partners LLC (“Consultant”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-004774","anchor_url":"https://secwatch.observer/filing/0001493152-26-004774#claim-63bd893fad5fd52b50ac23ef8378a88b1b92b7a7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315226004774/0001493152-26-004774-index.htm"},{"fact_type":"auditor_change","fact_key":"887978f2e172270f753ffc7b03df39a5a19d942b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-12-16T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"HTL International, LLC","disagreement_text":null,"effective_date":"2025-12-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"AIxCrypto Holdings, Inc. engaged HTL International, LLC as its auditor.","evidence_excerpt":"approved the engagement of HTL International, LLC (“HTL”) as the Company’s new independent registered public accounting firm","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-027824","anchor_url":"https://secwatch.observer/filing/0001493152-25-027824#claim-887978f2e172270f753ffc7b03df39a5a19d942b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225027824/0001493152-25-027824-index.htm"},{"fact_type":"auditor_change","fact_key":"3fde6c2bcfe8de9cb592b4a8c517f7b95d4e98f5","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-12-16T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Macias Gini & O'Connell LLP","disagreement_text":null,"effective_date":"2025-12-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"HTL International, LLC"},"claim":"AIxCrypto Holdings, Inc. dismissed Macias Gini & O'Connell LLP as its auditor.","evidence_excerpt":"terminated Macias Gini & O’Connell LLP (“MGO”) as the independent registered public accounting firm of the Company","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-027824","anchor_url":"https://secwatch.observer/filing/0001493152-25-027824#claim-3fde6c2bcfe8de9cb592b4a8c517f7b95d4e98f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225027824/0001493152-25-027824-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ebf4b8eeb50f373ccd092685a424c40435e8801b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-11-21T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-11-18","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5635(b)","reported_value":null,"rule_numbers":["5635(b)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq noncompliance notice notice regarding other (rules 5635(b)).","evidence_excerpt":"November 18, 2025, the Company received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”)\nof the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it failed to comply with Nasdaq’s shareholder\napproval requirements set forth in Nasdaq Listing Rule 5635(b) (the “Rule”), which requires shareholder approval prior to\nthe issuance of securities when the issuance or potential issuance will result in a change of control of the Company, in connection with\nthe Company’s private placement transaction (the “PIPE Financing”) that closed on September 29. 2025 (the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-024647","anchor_url":"https://secwatch.observer/filing/0001493152-25-024647#claim-ebf4b8eeb50f373ccd092685a424c40435e8801b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225024647/0001493152-25-024647-index.htm"},{"fact_type":"governance_change","fact_key":"678615cc351be2055e54a84de86a35113d72501e","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-11-17T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-11-14","item_codes_triggered":["5.03"],"summary_text":"Changed corporate name from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc."},"claim":"AIxCrypto Holdings, Inc.: Changed corporate name from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc (effective 2025-11-14).","evidence_excerpt":"On November 14, 2025, Qualigen Therapeutics, Inc. (the “Company”) filed with the State of Delaware a Certificate of Amendment to our Amended and Restated Certificate of Incorporation to change our corporate name from “Qualigen Therapeutics, Inc.” to “AIxCrypto Holdings, Inc.”","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-023728","anchor_url":"https://secwatch.observer/filing/0001493152-25-023728#claim-678615cc351be2055e54a84de86a35113d72501e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225023728/0001493152-25-023728-index.htm"},{"fact_type":"auditor_change","fact_key":"7e12fddb19671247fed22aa2db202fff09a7737a","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-10-07T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Macias Gini & O’Connell LLP","disagreement_text":null,"effective_date":"2025-10-03","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"AIxCrypto Holdings, Inc. engaged Macias Gini & O’Connell LLP as its auditor.","evidence_excerpt":"ctober 3, 2025, the Company’s Audit Committee approved the engagement of Macias Gini & O’Connell LLP (“MGO”)\nas the Company’s new independent registered public accounting firm for the final year ending December 31, 2025, and to perform","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-017162","anchor_url":"https://secwatch.observer/filing/0001493152-25-017162#claim-7e12fddb19671247fed22aa2db202fff09a7737a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225017162/0001493152-25-017162-index.htm"},{"fact_type":"auditor_change","fact_key":"b5255b03b725ec88d93f7e8314898f6727c00369","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-10-07T23:59:59+00:00","payload":{"action":"resignation","auditor_name":"WithumSmith+Brown, PC","disagreement_text":null,"effective_date":"2025-10-01","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Macias Gini & O’Connell LLP"},"claim":"WithumSmith+Brown, PC resigned as auditor of AIxCrypto Holdings, Inc..","evidence_excerpt":"Resignation\nof Independent Registered Public Accounting Firm On\nOctober 1, 2025, WithumSmith+Brown, PC (“Withum”) notified the Audit Committee of the Board of Directors (the “Audit\nCommittee”) of Qualigen Therapeutics, Inc. (the “Company”) that it had resigned as the Company’s independent\nregistered public accounting firm, effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-017162","anchor_url":"https://secwatch.observer/filing/0001493152-25-017162#claim-b5255b03b725ec88d93f7e8314898f6727c00369","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225017162/0001493152-25-017162-index.htm"},{"fact_type":"equity_issuance","fact_key":"0716e5a5c6abbc5b7718af89979b6768c4be248f","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-10-03T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"cash fee of 5.5% of gross proceeds and issuance of warrants","effective_date":"2025-09-29","item_codes_triggered":["3.02"],"purchaser":"Univest Securities LLC (Placement Agent)","security_type":"warrant","shares_text":"warrants to purchase number of shares equal to 6% of the securities sold in the Offering"},"claim":"AIxCrypto Holdings, Inc. issued warrants to purchase number of shares equal to 6% of the securities sold in the Offering of warrant to Univest Securities LLC (Placement Agent) for cash fee of 5.5% of gross proceeds and issuance of warrants.","evidence_excerpt":"the Company agreed to pay the Placement Agent a cash fee of 5.5% of the gross proceeds from the Offering and to issue to the Placement Agent (or its designees) warrants to purchase that number of shares of Common Stock equal to 6% of the securities sold in the Offering, which will be exercisable immediately following","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-016923","anchor_url":"https://secwatch.observer/filing/0001493152-25-016923#claim-0716e5a5c6abbc5b7718af89979b6768c4be248f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225016923/0001493152-25-016923-index.htm"},{"fact_type":"equity_issuance","fact_key":"c9d0863ac6f38f2b28b26a6f06c36d25dc19658e","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-10-03T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"cash consideration of $1,000 per share","effective_date":"2025-09-29","item_codes_triggered":["3.02"],"purchaser":"certain investors, including Faraday Future Intelligent Electric Inc.","security_type":"preferred_stock","shares_text":"17,783 shares"},"claim":"AIxCrypto Holdings, Inc. issued 17,783 shares of preferred stock to certain investors, including Faraday Future Intelligent Electric Inc. for cash consideration of $1,000 per share.","evidence_excerpt":"Preferred Stock, par value\n$0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price\nfor the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”),\nthe shares of Common Stock and Series B Stock were allocated among the investors so that no","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-016923","anchor_url":"https://secwatch.observer/filing/0001493152-25-016923#claim-c9d0863ac6f38f2b28b26a6f06c36d25dc19658e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225016923/0001493152-25-016923-index.htm"},{"fact_type":"equity_issuance","fact_key":"6db79c29b6945ba2d4e1c06ec5ef6274d8fe599d","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-10-03T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"cash consideration of $2.246 per share","effective_date":"2025-09-29","item_codes_triggered":["3.02"],"purchaser":"certain investors, including Faraday Future Intelligent Electric Inc.","security_type":"common_stock","shares_text":"337,432 shares"},"claim":"AIxCrypto Holdings, Inc. issued 337,432 shares of common stock to certain investors, including Faraday Future Intelligent Electric Inc. for cash consideration of $2.246 per share.","evidence_excerpt":"Stock”) and 17,783 shares of a newly created Series B Convertible Preferred Stock, par value\n$0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price\nfor the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”),\nthe shares of Common Stock and","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-016923","anchor_url":"https://secwatch.observer/filing/0001493152-25-016923#claim-6db79c29b6945ba2d4e1c06ec5ef6274d8fe599d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225016923/0001493152-25-016923-index.htm"},{"fact_type":"equity_issuance","fact_key":"3e771d04d58575f29b415514b08f0605ecf830eb","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-09-25T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"$2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash","effective_date":"2025-09-19","item_codes_triggered":["3.02"],"purchaser":"certain investors, including Faraday Future Intelligent Electric Inc.","security_type":"preferred_stock","shares_text":"$41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock"},"claim":"AIxCrypto Holdings, Inc. issued $41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock of preferred stock to certain investors, including Faraday Future Intelligent Electric Inc. for $2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash.","evidence_excerpt":"“Common Stock”) and shares\nof a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase\nprice of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated\nValue”). At the closing of the Offering (the “Closing”), the shares of Common Stock and","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-014965","anchor_url":"https://secwatch.observer/filing/0001493152-25-014965#claim-3e771d04d58575f29b415514b08f0605ecf830eb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225014965/0001493152-25-014965-index.htm"},{"fact_type":"equity_issuance","fact_key":"fc672212b343724019f29e17e05919e4b8c4df97","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-09-25T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"$2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash","effective_date":"2025-09-19","item_codes_triggered":["3.02"],"purchaser":"certain investors, including Faraday Future Intelligent Electric Inc.","security_type":"common_stock","shares_text":"$41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock"},"claim":"AIxCrypto Holdings, Inc. issued $41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock of common stock to certain investors, including Faraday Future Intelligent Electric Inc. for $2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash.","evidence_excerpt":"“Common Stock”) and shares\nof a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase\nprice of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated\nValue”). At the closing of the Offering (the “Closing”), the shares of Common Stock and","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-014965","anchor_url":"https://secwatch.observer/filing/0001493152-25-014965#claim-fc672212b343724019f29e17e05919e4b8c4df97","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315225014965/0001493152-25-014965-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"1393fb20b716d778781a444b2ec2616b77383507","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-09-08T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"extension_granted","cure_deadline":"2025-11-15","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2.5 million","notice_date":"2025-09-04","notice_type":"extension_granted","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":"negative $1.6 million","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"September 4, 2025, Qualigen Therapeutics, Inc. (the “Company”) received a written decision (the “Decision Letter”)\nfrom the Nasdaq Hearings Panel (the “Panel”) in response to the Company’s August 19, 2025 update and request for a\ncompliance determination with respect to the Panel’s July 24, 2025 decision, as amended. As\npreviously disclosed, on July 24, 2025, the Panel granted the Company an exception to remain listed on The Nasdaq Capital Market, conditioned\non demonstrating compliance with Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”), which requires companies to maintain\nstockholders’","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-026864","anchor_url":"https://secwatch.observer/filing/0001641172-25-026864#claim-1393fb20b716d778781a444b2ec2616b77383507","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225026864/0001641172-25-026864-index.htm"},{"fact_type":"debt_financing","fact_key":"2f38c58935e05be0e4a0c9c62694b30f57e06ecd","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-08-27T23:59:59+00:00","payload":{"counterparty":"Marizyme, Inc.","effective_date":"2025-08-21","event":"amendment","instrument_type":"loan","interest_rate_text":"18% per annum","item_codes_triggered":["2.03"],"maturity_text":"August 21, 2026","principal_text":"$4,451,462.18"},"claim":"AIxCrypto Holdings, Inc. amended loan of $4,451,462.18 with Marizyme, Inc. at 18% per annum maturing August 21, 2026.","evidence_excerpt":"The Amended Note has a principal balance of $4,451,462.18, which represents (i) the outstanding balance of the Prior Note, (ii) accrued and unpaid interest thereon, and (iii) an additional advance of $216,000 made by the Company to Marizyme on the date of the Amended Note. The Amended Note bears interest at a rate of 18% per annum, with all accrued interest and the full principal balance due in a single balloon payment on August 21, 2026 (subject to earlier demand upon an event of default).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-025702","anchor_url":"https://secwatch.observer/filing/0001641172-25-025702#claim-2f38c58935e05be0e4a0c9c62694b30f57e06ecd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/0001641172-25-025702-index.htm"},{"fact_type":"governance_change","fact_key":"5fd34e447ff46adc2d0667caff18323d0d229ad4","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-07-28T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-07-28","item_codes_triggered":["5.03"],"summary_text":"Company filed Second Amended and Restated Certificate of Designation for Series A-3 Preferred Stock"},"claim":"AIxCrypto Holdings, Inc.: Company filed Second Amended and Restated Certificate of Designation for Series A-3 Preferred Stock (effective 2025-07-28).","evidence_excerpt":"On July 28, 2025, in connection with the private placement described under Item 1.01 of this Current Report on Form 8-K, the Company filed a Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A-3 Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-021174","anchor_url":"https://secwatch.observer/filing/0001641172-25-021174#claim-5fd34e447ff46adc2d0667caff18323d0d229ad4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225021174/0001641172-25-021174-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"8ca791db363db4e0cddacb45fbafe3ebcd9f68c8","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-07-28T23:59:59+00:00","payload":{"company_response":"compliance plan submitted and accepted","compliance_status":"extension_granted","cure_deadline":"extension granted","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2.5 million stockholders' equity","notice_date":"2025-07-24","notice_type":"deficiency_notice","plan_due_date":"accepted","raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":"compliance regained pro forma","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"July 24, 2025, the Company received a follow-up communication from the Office of the General Counsel of Nasdaq confirming that Nasdaq\nhad granted the Company’s request for an extension to regain compliance. Nasdaq acknowledged that: The\nCompany timely filed its Quarterly Report on Form 10-Q on or before the required deadline of July 21, 2025; The\nCompany has demonstrated compliance with the Equity Rule on a pro forma basis following the closing of a $4.5 million private placement\nof Series A-3 Preferred Stock, before customary fees and expenses; and The\nCompany submitted a compliance plan outl","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-021198","anchor_url":"https://secwatch.observer/filing/0001641172-25-021198#claim-8ca791db363db4e0cddacb45fbafe3ebcd9f68c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225021198/0001641172-25-021198-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"caa8f985a532c8c37d168384a845b55092341e2a","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-05-19T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-05-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 19, 2025, Qualigen Therapeutics, Inc. (the “Company”) received an expected deficiency\nnotification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on May 19, 2025 (the\n“Notice”). The Notice indicated that the Nasdaq Hearings Panel (the “Panel”) will consider the Company’s\nfailure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 as an additional basis for delisting the\nCompany’s securities from The Nasdaq Stock Market . This\nmatter serves as an additional deficiency under Nasdaq Listing Rule 5250(c)(1), which require","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-011530","anchor_url":"https://secwatch.observer/filing/0001641172-25-011530#claim-caa8f985a532c8c37d168384a845b55092341e2a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225011530/0001641172-25-011530-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7def57ad995b538aaf7fb78bc636c9760eb17de6","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-05-01T23:59:59+00:00","payload":{"company_response":"intends to appeal to Nasdaq","compliance_status":"delisting_pending","cure_deadline":"2025-05-01","deficiency_type":"late_filing","delisting_effective_date":"2025-05-05","exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-04-24","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)).","evidence_excerpt":"April 24, 2025, the Company received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying\nthe Company that, because the Company is delinquent in filing the 2024 Form 10-K, the Company no longer complies with Nasdaq Listing\nRule 5250(c) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required\nperiodic reports with the SEC. Therefore,\nin line with the Panel Monitor’s decision, the Company’s securities will be delisted from Nasdaq. If the Company does\nnot request an appeal of this decision by May 1, 2025, trading of the C","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-008110","anchor_url":"https://secwatch.observer/filing/0001641172-25-008110#claim-7def57ad995b538aaf7fb78bc636c9760eb17de6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225008110/0001641172-25-008110-index.htm"},{"fact_type":"executive_change","fact_key":"c6ec65411f","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-11-13T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-07","interim":false,"role":"independent director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Graydon Bensler was appointed as independent director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On November 7, 2024, the Board of Directors (the “Board”) appointed Graydon Bensler as an independent member of the Board, effective immediately","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-045184","anchor_url":"https://secwatch.observer/filing/0001493152-24-045184#claim-c6ec65411f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224045184/0001493152-24-045184-index.htm"},{"fact_type":"governance_change","fact_key":"7aed67161fe22750d7012b441381acd90e8274d6","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-11-01T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-11-05","item_codes_triggered":["5.03"],"summary_text":"Effect a 1-for-50 reverse stock split of common stock"},"claim":"AIxCrypto Holdings, Inc.: Effect a 1-for-50 reverse stock split of common stock (effective 2024-11-05).","evidence_excerpt":"On October 28, 2024, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding Common Stock, effective November 5, 2024 at 12:01 a.m., Eastern Time (the “Effective Time”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-043352","anchor_url":"https://secwatch.observer/filing/0001493152-24-043352#claim-7aed67161fe22750d7012b441381acd90e8274d6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224043352/0001493152-24-043352-index.htm"},{"fact_type":"executive_change","fact_key":"5de1f83229","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-10-09T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-10-08","interim":false,"role":"Independent Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Braeden Lichti was appointed as Independent Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-040599","anchor_url":"https://secwatch.observer/filing/0001493152-24-040599#claim-5de1f83229","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm"},{"fact_type":"executive_change","fact_key":"b7fc05b45b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-10-09T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-10-03","interim":false,"role":"Independent Director and Chairman of Audit Committee","role_category":"director","successor_name":null,"successor_named":false},"claim":"Matt Korenberg resigned as Independent Director and Chairman of Audit Committee at AIxCrypto Holdings, Inc..","evidence_excerpt":"On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-040599","anchor_url":"https://secwatch.observer/filing/0001493152-24-040599#claim-b7fc05b45b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm"},{"fact_type":"executive_change","fact_key":"e70e007986","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-26","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kevin Richardson II was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"as well as a member of the board of directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-038351","anchor_url":"https://secwatch.observer/filing/0001493152-24-038351#claim-e70e007986","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm"},{"fact_type":"executive_change","fact_key":"da2dc718b0","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-26","interim":true,"role":"Interim Chief Executive Officer and Interim Chief Financial Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Kevin Richardson II was appointed as Interim Chief Executive Officer and Interim Chief Financial Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"the Board of Directors appointed Kevin Richardson II as the Interim Chief Executive Officer and Interim Chief Financial Officer, as well as a member of the board of directors of the Company (the “Interim CEO and CFO”), effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-038351","anchor_url":"https://secwatch.observer/filing/0001493152-24-038351#claim-da2dc718b0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm"},{"fact_type":"executive_change","fact_key":"894b1e0535","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-25","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Campbell Becher was appointed as President at AIxCrypto Holdings, Inc..","evidence_excerpt":"the board of directors (the “Board”) appointed Campbell Becher as President of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-038351","anchor_url":"https://secwatch.observer/filing/0001493152-24-038351#claim-894b1e0535","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm"},{"fact_type":"executive_change","fact_key":"3b13ed04bb","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-26T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"for_cause_or_dispute","effective_date":"2024-09-23","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Kevin Richardson II","successor_named":true},"claim":"Christopher Lotz resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"Mr. Christopher Lotz, Chief Financial Officer of the Company, also tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-038351","anchor_url":"https://secwatch.observer/filing/0001493152-24-038351#claim-3b13ed04bb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm"},{"fact_type":"executive_change","fact_key":"e25fe1242e","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-09-26T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"for_cause_or_dispute","effective_date":"2024-09-23","interim":false,"role":"Chief Executive Officer and Chairman","role_category":"ceo","successor_name":"Kevin Richardson II","successor_named":true},"claim":"Michael Poirier resigned as Chief Executive Officer and Chairman at AIxCrypto Holdings, Inc..","evidence_excerpt":"Mr. Michael Poirier, Chief Executive Officer and Chairman of the board of directors of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-038351","anchor_url":"https://secwatch.observer/filing/0001493152-24-038351#claim-e25fe1242e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm"},{"fact_type":"executive_change","fact_key":"32376d2f82","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Cody Price was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-32376d2f82","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"e59afabe95","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Robert Lim was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-e59afabe95","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"3baf02d82f","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Campbell Becher was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-3baf02d82f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"07bb2523f8","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Ira Ritter resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-07bb2523f8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"dc0b92a110","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kurt Kruger resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-dc0b92a110","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"d29e942223","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Sidney Emery resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-d29e942223","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"daff216376","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-15T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Richard David resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027217","anchor_url":"https://secwatch.observer/filing/0001493152-24-027217#claim-daff216376","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027217/0001493152-24-027217-index.htm"},{"fact_type":"executive_change","fact_key":"62d800e05b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Cody Price was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-62d800e05b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"1ea88262e5","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Robert Lim was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-1ea88262e5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"354b8c027c","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Campbell Becher was appointed as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-354b8c027c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"ece3a54401","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Ira Ritter resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-ece3a54401","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"1bd4b17e4a","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kurt Kruger resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-1bd4b17e4a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"32ee5d0db7","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Sidney Emery resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-32ee5d0db7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"executive_change","fact_key":"8b118310b8","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-07-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Richard David resigned as Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-027015","anchor_url":"https://secwatch.observer/filing/0001493152-24-027015#claim-8b118310b8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224027015/0001493152-24-027015-index.htm"},{"fact_type":"debt_financing","fact_key":"aeae697f66f123c045aa6db870e75af100eb0bf5","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-04-16T23:59:59+00:00","payload":{"counterparty":"Yi Hua Chen","effective_date":"2024-04-12","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"8% per annum","item_codes_triggered":["2.03"],"maturity_text":"December 31, 2024","principal_text":"$1,100,000"},"claim":"AIxCrypto Holdings, Inc. incurred convertible notes of $1,100,000 with Yi Hua Chen at 8% per annum maturing December 31, 2024.","evidence_excerpt":"On April 12, 2024, against Chen’s Option exercise price of $1,000,000 paid to us, we delivered to Chen: - an 8% Convertible Debenture (the “Chen Debenture”) in the principal amount of $1,100,000, of like tenor as the Alpha Debenture except for the principal amount","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-014821","anchor_url":"https://secwatch.observer/filing/0001493152-24-014821#claim-aeae697f66f123c045aa6db870e75af100eb0bf5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224014821/0001493152-24-014821-index.htm"},{"fact_type":"material_agreement","fact_key":"2cfdf198050840966ecbe1995a303be5500d157a","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-03-28T23:59:59+00:00","payload":{"action":"termination","agreement_name":"License and Sublicense Agreement","agreement_type":"license","counterparty":"Pan-RAS Holdings, Inc.","effective_date":"2024-03-25","item_codes_triggered":["1.02"],"value_text":null},"claim":"AIxCrypto Holdings, Inc. terminated License and Sublicense Agreement with Pan-RAS Holdings, Inc. (effective 2024-03-25).","evidence_excerpt":"On March 25, 2024, as of March 16, 2024, we entered into a Termination Agreement with Pan-RAS Holdings, Inc., a New York corporation (“ Pan-RAS Holdings ”). The Termination Agreement terminated, without liability on either party, the License and Sublicense Agreement dated February 15, 2024 between us and Pan-RAS Holdings (the “ License and Sublicense Agreement ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-011732","anchor_url":"https://secwatch.observer/filing/0001493152-24-011732#claim-2cfdf198050840966ecbe1995a303be5500d157a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224011732/0001493152-24-011732-index.htm"},{"fact_type":"material_agreement","fact_key":"ce11b6726dcedf8c49ba23fa6c1406bb40804be7","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-02-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Alpha Capital Anstalt","effective_date":"2024-02-26","item_codes_triggered":["1.01"],"value_text":"$500,000"},"claim":"AIxCrypto Holdings, Inc. entered into Securities Purchase Agreement with Alpha Capital Anstalt valued at $500,000 (effective 2024-02-26).","evidence_excerpt":"On February 26, 2024, Qualigen Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (“Agreement”) with Alpha Capital Anstalt (“Alpha”). The transactions contemplated by the Agreement are expected to close on February 27, 2024, at which time the Company would deliver to Alpha the Debenture and the Warrant, as described below, and Alpha would pay the Company a cash purchase price of $500,000 (less expenses).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-007928","anchor_url":"https://secwatch.observer/filing/0001493152-24-007928#claim-ce11b6726dcedf8c49ba23fa6c1406bb40804be7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224007928/0001493152-24-007928-index.htm"},{"fact_type":"executive_change","fact_key":"269365f116","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-02-27T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-02-25","interim":false,"role":"Senior Vice President/Chief Medical Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Tariq Arshad resigned as Senior Vice President/Chief Medical Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"On February 25, 2024, Tariq Arshad resigned from his position as the Company’s Senior Vice President/Chief Medical Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007928","anchor_url":"https://secwatch.observer/filing/0001493152-24-007928#claim-269365f116","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224007928/0001493152-24-007928-index.htm"},{"fact_type":"material_agreement","fact_key":"d961ea9cf0a05ced0e700bb10ac7eefc3dc060fb","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-12-07T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment No. 1","agreement_type":"equity_purchase","counterparty":"Alpha Capital Anstalt","effective_date":"2023-12-05","item_codes_triggered":["1.01"],"value_text":null},"claim":"AIxCrypto Holdings, Inc. amended Amendment No. 1 with Alpha Capital Anstalt (effective 2023-12-05).","evidence_excerpt":"On December 5, 2023, we entered into an Amendment No. 1 with regard to Securities Purchase Agreement, with Alpha Capital Anstalt.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-044019","anchor_url":"https://secwatch.observer/filing/0001493152-23-044019#claim-d961ea9cf0a05ced0e700bb10ac7eefc3dc060fb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223044019/0001493152-23-044019-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"bf25e5aa0d3ea6ad87369ecd0341e151c2f51506","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-11-22T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2025-01-05","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2,500,000","notice_date":"2023-11-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":"($1,640,552)","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 21, 2023, the Company also received a letter (the “Equity Deficiency Letter”) from Nasdaq notifying the Company\nthat, based on the Company’s stockholders’ deficit of ($1,640,552) as of September 30, 2023, as reported in the Company’s\nQuarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, it is no longer in compliance with the minimum stockholders’\nequity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1), which requires listed companies\nto maintain stockholders’ equity of at least $2.5 million (the “Minimum Sto","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-042508","anchor_url":"https://secwatch.observer/filing/0001493152-23-042508#claim-bf25e5aa0d3ea6ad87369ecd0341e151c2f51506","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223042508/0001493152-23-042508-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"61f6eea86b919f41ee8033b52f781def571a24f5","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-11-22T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2024-05-20","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2023-11-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"November 21, 2023, the Company also received a letter (the “Equity Deficiency Letter”) from Nasdaq notifying the Company\nthat, based on the Company’s stockholders’ deficit of ($1,640,552) as of September 30, 2023, as reported in the Company’s\nQuarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, it is no longer in compliance with the minimum stockholders’\nequity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1), which requires listed companies\nto maintain stockholders’ equity of at least $2.5 million (the “Minimum Sto","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-042508","anchor_url":"https://secwatch.observer/filing/0001493152-23-042508#claim-61f6eea86b919f41ee8033b52f781def571a24f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223042508/0001493152-23-042508-index.htm"},{"fact_type":"material_agreement","fact_key":"52224001f067e4885a0716b50673218c9674147b","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-09-28T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Waiver","agreement_type":"notes_offering","counterparty":"Alpha Capital Anstalt","effective_date":"2023-09-22","item_codes_triggered":["1.01"],"value_text":"$3,300,000"},"claim":"AIxCrypto Holdings, Inc. entered into Waiver with Alpha Capital Anstalt valued at $3,300,000 (effective 2023-09-22).","evidence_excerpt":"On September 22, 2023, Qualigen Therapeutics, Inc. (the “Company”) entered into a consent and waiver (the “Waiver”) with Alpha Capital Anstalt (“Alpha”) with respect to the 8% Senior Convertible Debenture in the aggregate principal amount of $3,300,000 issued by the Company to Alpha on December 22, 2022 (the “Debenture”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-034627","anchor_url":"https://secwatch.observer/filing/0001493152-23-034627#claim-52224001f067e4885a0716b50673218c9674147b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm"},{"fact_type":"earnings_release","fact_key":"bc354ef86dbf7377c45584cb722338b81eb9490e","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-08-15T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter ended June 30, 2023","report_date":"2023-08-15","result_type":"reported_results","revenue_text":"approximately $1.6 million"},"claim":"AIxCrypto Holdings, Inc. reported the quarter ended June 30, 2023 results: revenue approximately $1.6 million.","evidence_excerpt":"Revenues from product sales for the quarter ended June 30, 2023 were approximately $1.6 million compared to approximately $1.4 million for the same period of 2022","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-028863","anchor_url":"https://secwatch.observer/filing/0001493152-23-028863#claim-bc354ef86dbf7377c45584cb722338b81eb9490e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223028863/0001493152-23-028863-index.htm"},{"fact_type":"ma_transaction","fact_key":"9064e8ee2f5da52f625c7caf0601b4568c7fd1a0","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-26T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2023-07-20","consideration_text":"$5.1 million in cash","counterparty":"Chembio Diagnostics, Inc.","effective_date":"2023-07-20","item_codes_triggered":["2.01"]},"claim":"AIxCrypto Holdings, Inc. completed a disposition involving Chembio Diagnostics, Inc. for $5.1 million in cash (closed 2023-07-20).","evidence_excerpt":"the consummation of the Transaction, the Subsidiary became a wholly-owned\nsubsidiary of the Buyer. The aggregate net purchase price\npaid to the Company for the Shares was $5.1 million in cash, based on a base purchase price of $5.8 million, subject\nto certain post-closing adjustments, upward or downward, as applicable, for: (i) cash held by the Subsidiary as","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-025606","anchor_url":"https://secwatch.observer/filing/0001493152-23-025606#claim-9064e8ee2f5da52f625c7caf0601b4568c7fd1a0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223025606/0001493152-23-025606-index.htm"},{"fact_type":"material_agreement","fact_key":"d2498ed7d722f40e441adc6481c46b69b15bb5c0","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-26T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Nanosynex Amendment","agreement_type":"settlement","counterparty":"Nanosynex Ltd.","effective_date":"2023-07-20","item_codes_triggered":["1.01"],"value_text":"aggregate amount of $1,610,000"},"claim":"AIxCrypto Holdings, Inc. amended Nanosynex Amendment with Nanosynex Ltd. valued at aggregate amount of $1,610,000 (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, the Company entered into an Amendment and Settlement Agreement with Nanosynex Ltd. (the “Nanosynex Amendment”), which amended the Master Funding Agreement for the Operational and Technology Funding of Nanosynex Ltd. (“Nanosynex”), dated May 26, 2022, by and between the Company and Nanosynex (the “Original Nanosynex Agreement”), a majority owned subsidiary of the Company, to, among other things, provide for the further funding of Nanosynex, as contemplated by the Original Nanosynex Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-025606","anchor_url":"https://secwatch.observer/filing/0001493152-23-025606#claim-d2498ed7d722f40e441adc6481c46b69b15bb5c0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223025606/0001493152-23-025606-index.htm"},{"fact_type":"material_agreement","fact_key":"abb407005f2f7e519320e8867aa684d63509b9c9","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-26T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Chembio Diagnostics, Inc. and Biosynex, S.A.","effective_date":"2023-07-20","item_codes_triggered":["1.01"],"value_text":"$5.1 million in cash, based on a base purchase price of $5.8 million"},"claim":"AIxCrypto Holdings, Inc. entered into Purchase Agreement with Chembio Diagnostics, Inc. and Biosynex, S.A. valued at $5.1 million in cash, based on a base purchase price of $5.8 million (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, Qualigen Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a stock purchase agreement (the “Purchase Agreement”) with Chembio Diagnostics, Inc. (the “Buyer”), Biosynex, S.A. (“Biosynex”), and Qualigen, Inc., a wholly-owned subsidiary of the Company (the “Subsidiary”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-025606","anchor_url":"https://secwatch.observer/filing/0001493152-23-025606#claim-abb407005f2f7e519320e8867aa684d63509b9c9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223025606/0001493152-23-025606-index.htm"},{"fact_type":"shareholder_vote","fact_key":"908bc6ae795f800a3aa0e06034a83255b5690c87","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-13","outcome":"passed","proposal_text":"Proposal to approve, on a non-binding, advisory basis, the compensation of our named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,594,197","subject":null,"votes_abstain":"16,203","votes_against":"206,074","votes_for":"477,848","votes_withheld":null}]},"claim":"AIxCrypto Holdings, Inc. shareholders approved Proposal to approve, on a non-binding, advisory basis, the compensation of our named executive officers at the 2023-07-13 meeting.","evidence_excerpt":"4. Proposal to approve, on a non-binding, advisory basis, the compensation of our named executive officers: Votes Abstaining Broker Non-Votes 477,848 206,074 16,203 1,594,197 The proposal was approved.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-024516","anchor_url":"https://secwatch.observer/filing/0001493152-23-024516#claim-908bc6ae795f800a3aa0e06034a83255b5690c87","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223024516/0001493152-23-024516-index.htm"},{"fact_type":"shareholder_vote","fact_key":"10b65efcc51aa3816d577e11580226b230933560","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-13","outcome":"passed","proposal_text":"Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance to Alpha Capital Anstalt (“Alpha”) of more than 20% of the Company’s issued and outstanding common stock pursuant to the terms and conditions of (a) the 8% Senior Convertible Debenture Due December 22, 2025","proposal_type":"other","results":[{"broker_non_votes":"1,594,197","subject":null,"votes_abstain":"11,085","votes_against":"223,070","votes_for":"465,970","votes_withheld":null}]},"claim":"AIxCrypto Holdings, Inc. shareholders approved Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance to Alpha Capital Anstalt (“Alpha”) of more than 20% of the Company’s issued and outstanding common stock pursuant to the terms and conditions of (a) the 8% Senior Convertible Debenture Due December 22, 2025 at the 2023-07-13 meeting.","evidence_excerpt":"3. Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance to Alpha Capital Anstalt (“Alpha”) of more than 20% of the Company’s issued and outstanding common stock pursuant to the terms and conditions of (a) the 8% Senior Convertible Debenture Due December 22, 2025 in favor of Alpha, and (b) the Company’s common stock purchase warrant dated December 22, 2022 issued to Alpha Votes Abstaining Broker Non-Votes 465,970 223,070 11,085 1,594,197 The proposal was approved.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-024516","anchor_url":"https://secwatch.observer/filing/0001493152-23-024516#claim-10b65efcc51aa3816d577e11580226b230933560","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223024516/0001493152-23-024516-index.htm"},{"fact_type":"shareholder_vote","fact_key":"c5fd20ba50c9fed9722aa1644e5835108b4b86c4","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-13","outcome":"passed","proposal_text":"Proposal to ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"29,134","votes_against":"163,263","votes_for":"2,101,925","votes_withheld":null}]},"claim":"AIxCrypto Holdings, Inc. shareholders approved Proposal to ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-07-13 meeting.","evidence_excerpt":"2. Proposal to ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023: Votes Abstaining 2,101,925 163,263 29,134 The proposal was approved.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-024516","anchor_url":"https://secwatch.observer/filing/0001493152-23-024516#claim-c5fd20ba50c9fed9722aa1644e5835108b4b86c4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223024516/0001493152-23-024516-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f957d01598cda2e7cf7e82a2e6913b6b858448fc","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-07-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-07-13","outcome":"passed","proposal_text":"Election of Six Director Nominees","proposal_type":"director_election","results":[{"broker_non_votes":"1,594,197","subject":"Michael Poirier","votes_abstain":null,"votes_against":null,"votes_for":"501,410","votes_withheld":"198,715"},{"broker_non_votes":"1,594,197","subject":"Richard David","votes_abstain":null,"votes_against":null,"votes_for":"529,104","votes_withheld":"171,021"},{"broker_non_votes":"1,594,197","subject":"Sidney Emery, Jr.","votes_abstain":null,"votes_against":null,"votes_for":"503,712","votes_withheld":"196,413"},{"broker_non_votes":"1,594,197","subject":"Matthew Korenberg","votes_abstain":null,"votes_against":null,"votes_for":"513,635","votes_withheld":"186,490"},{"broker_non_votes":"1,594,197","subject":"Kurt Kruger","votes_abstain":null,"votes_against":null,"votes_for":"498,936","votes_withheld":"201,189"},{"broker_non_votes":"1,594,197","subject":"Ira Ritter","votes_abstain":null,"votes_against":null,"votes_for":"529,686","votes_withheld":"170,439"}]},"claim":"AIxCrypto Holdings, Inc. shareholders approved Election of Six Director Nominees at the 2023-07-13 meeting.","evidence_excerpt":"1. Election of Six Director Nominees: Votes Withheld Broker Non-Votes Michael Poirier 501,410 198,715 1,594,197 Richard David 529,104 171,021 1,594,197 Sidney Emery, Jr. 503,712 196,413 1,594,197 Matthew Korenberg 513,635 186,490 1,594,197 Kurt Kruger 498,936 201,189 1,594,197 Ira Ritter 529,686 170,439 1,594,197 Each director nominee was elected to serve as a director until the Company’s annual meeting of stockholders in 2024, or until such person’s successor is duly elected and qualified or until such person’s earlier resignation, death, or removal.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-024516","anchor_url":"https://secwatch.observer/filing/0001493152-23-024516#claim-f957d01598cda2e7cf7e82a2e6913b6b858448fc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223024516/0001493152-23-024516-index.htm"},{"fact_type":"executive_change","fact_key":"3c2b017d6c","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-06-26T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-06-16","interim":false,"role":"President, Chief Strategy and Operating Officer","role_category":"president","successor_name":null,"successor_named":false},"claim":"Amy Broidrick resigned as President, Chief Strategy and Operating Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"Amy Broidrick, President, Chief Strategy and Operating Officer and a director of Qualigen Therapeutics, Inc. (the “Company”), provided her resignation to the Company, which became effective June 16, 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-022531","anchor_url":"https://secwatch.observer/filing/0001493152-23-022531#claim-3c2b017d6c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223022531/0001493152-23-022531-index.htm"},{"fact_type":"executive_change","fact_key":"4025de5426","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-05-19T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-06-16","interim":false,"role":"President, Chief Strategy and Operating Officer and Director","role_category":"president","successor_name":null,"successor_named":false},"claim":"Amy Broidrick resigned as President, Chief Strategy and Operating Officer and Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On May 16, 2023, Amy Broidrick, President, Chief Strategy and Operating Officer and a director of Qualigen Therapeutics, Inc. (the “Company”), provided her resignation to the Company, which will become effective June 16, 2023 (the “Effective Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-018231","anchor_url":"https://secwatch.observer/filing/0001493152-23-018231#claim-4025de5426","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223018231/0001493152-23-018231-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"41d4ebf7f123c70577ad27b00537359af5066129","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-05-05T23:59:59+00:00","payload":{"company_response":"filed Form 10-K","compliance_status":"regained_compliance","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-05-04","notice_type":"compliance_regained","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 4, 2023 that it had regained\ncompliance with Nasdaq’s listing rule 5250(c)(1) as a result thereof and that the matter is now closed. SIGNATURES Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized. QUALIGEN\n THERAPEUTICS, INC. Date:\n May 5, 2023 By: /s/ Michael S. Poirier Michael\n S. Poirier, Chief Executive Officer","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-015599","anchor_url":"https://secwatch.observer/filing/0001493152-23-015599#claim-41d4ebf7f123c70577ad27b00537359af5066129","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223015599/0001493152-23-015599-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"0c720f6d83d84fa510d65f5efcc0756d578f3e61","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-04-24T23:59:59+00:00","payload":{"company_response":"intends to file Form 10-K as soon as practicable and prior to the Plan Deadline","compliance_status":"deficient","cure_deadline":"60 calendar days to submit a plan","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-04-20","notice_type":"deficiency_notice","plan_due_date":"2023-06-19","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"April 20, 2023, Qualigen Therapeutics, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq\nStock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form\n10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”), the Company is no longer in compliance with the timely\nfiling requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies\nto timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-013314","anchor_url":"https://secwatch.observer/filing/0001493152-23-013314#claim-0c720f6d83d84fa510d65f5efcc0756d578f3e61","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223013314/0001493152-23-013314-index.htm"},{"fact_type":"executive_change","fact_key":"9ce78310ea","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-01-20T23:59:59+00:00","payload":{"action":"title will become","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2023-02-16","interim":false,"role":"President, Chief Strategy and Operating Officer","role_category":"president","successor_name":null,"successor_named":false},"claim":"Amy Broidrick changed role as President, Chief Strategy and Operating Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"Ms. Broidrick’s title will become President, Chief Strategy and Operating Officer, effective as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-002034","anchor_url":"https://secwatch.observer/filing/0001493152-23-002034#claim-9ce78310ea","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm"},{"fact_type":"executive_change","fact_key":"5e5404bf1d","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-01-20T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2023-02-16","interim":false,"role":"Chief Operating Officer and Senior Vice President, Diagnostics","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Shishir Sinha was terminated as Chief Operating Officer and Senior Vice President, Diagnostics at AIxCrypto Holdings, Inc..","evidence_excerpt":"the Company provided notice to Mr. Sinha that his employment with the Company would be terminated effective February 16, 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-002034","anchor_url":"https://secwatch.observer/filing/0001493152-23-002034#claim-5e5404bf1d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm"},{"fact_type":"debt_financing","fact_key":"023bb58750a2fc60ee86e8ed5d87e94405d25cb7","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2022-12-22T23:59:59+00:00","payload":{"counterparty":"Alpha Capital Anstalt","effective_date":"2022-12-22","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"8% per annum","item_codes_triggered":["2.03"],"maturity_text":"December 22, 2025","principal_text":"$3,300,000"},"claim":"AIxCrypto Holdings, Inc. incurred convertible notes of $3,300,000 with Alpha Capital Anstalt at 8% per annum maturing December 22, 2025.","evidence_excerpt":"Alpha Capital Anstalt (“Alpha”), pursuant to which it agreed to issue to Alpha, an 8% Senior Convertible Debenture (the\n“Debenture”) in the aggregate principal amount of $3,300,000 for a purchase price of $3,000,000. The Debenture will be convertible,\nat any time, and from time to time, at Alpha’s option, into shares of common stock of the Company (the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-036302","anchor_url":"https://secwatch.observer/filing/0001493152-22-036302#claim-023bb58750a2fc60ee86e8ed5d87e94405d25cb7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315222036302/0001493152-22-036302-index.htm"},{"fact_type":"material_agreement","fact_key":"cb5c3f3eeff4b1844769828922429ee30470ec90","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2022-12-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Alpha Capital Anstalt","effective_date":"2022-12-21","item_codes_triggered":["1.01"],"value_text":"$3,300,000"},"claim":"AIxCrypto Holdings, Inc. entered into Securities Purchase Agreement with Alpha Capital Anstalt valued at $3,300,000 (effective 2022-12-21).","evidence_excerpt":"On December 21, 2022, Qualigen Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (“Agreement”) with Alpha Capital Anstalt (“Alpha”), pursuant to which it agreed to issue to Alpha, an 8% Senior Convertible Debenture (the “Debenture”) in the aggregate principal amount of $3,300,000 for a purchase price of $3,000,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-036302","anchor_url":"https://secwatch.observer/filing/0001493152-22-036302#claim-cb5c3f3eeff4b1844769828922429ee30470ec90","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315222036302/0001493152-22-036302-index.htm"},{"fact_type":"governance_change","fact_key":"53c7a0827a91d5818249cdf7c1ddd335e5674387","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2022-11-22T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2022-11-23","item_codes_triggered":["5.03"],"summary_text":"公司提交了公司章程修正案以实施1比10的反向股票拆分"},"claim":"AIxCrypto Holdings, Inc.: 公司提交了公司章程修正案以实施1比10的反向股票拆分 (effective 2022-11-23).","evidence_excerpt":"On November 21, 2022, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding Common Stock, effective November 23, 2022 at 12:01 a.m., Eastern Time (the “Effective Time”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-033252","anchor_url":"https://secwatch.observer/filing/0001493152-22-033252#claim-53c7a0827a91d5818249cdf7c1ddd335e5674387","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315222033252/0001493152-22-033252-index.htm"},{"fact_type":"shareholder_vote","fact_key":"06d2c24045f41ef44125b6de7ad133738c33e647","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2022-10-28T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-10-28","outcome":"passed","proposal_text":"Approve an amendment to the certificate of incorporation to effect a reverse stock split of common stock at a ratio within 1-for-5 to 1-for-10","proposal_type":"reverse_split","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"99,677","votes_against":"5,072,906","votes_for":"19,659,769","votes_withheld":null}]},"claim":"AIxCrypto Holdings, Inc. shareholders approved Approve an amendment to the certificate of incorporation to effect a reverse stock split of common stock at a ratio within 1-for-5 to 1-for-10 at the 2022-10-28 meeting.","evidence_excerpt":"At the reconvened Annual Meeting, the stockholders approved Proposal 4 by the following votes: Votes For Votes Against Votes Abstaining 19,659,769 5,072,906 99,677","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-029876","anchor_url":"https://secwatch.observer/filing/0001493152-22-029876#claim-06d2c24045f41ef44125b6de7ad133738c33e647","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315222029876/0001493152-22-029876-index.htm"},{"fact_type":"executive_change","fact_key":"1ba4da8942","cik":1460702,"ticker":"AIXC","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2021-12-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2021-12-10","interim":false,"role":"President/Chief Strategy Officer","role_category":"president","successor_name":null,"successor_named":false},"claim":"Amy Broidrick was appointed as President/Chief Strategy Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"On December 8, 2021, our Board appointed Amy Broidrick, who had been serving as our Executive Vice President/Chief Strategy Officer since December 2020, to the position of President/Chief Strategy Officer (effective December 10, 2021).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-21-031101","anchor_url":"https://secwatch.observer/filing/0001493152-21-031101#claim-1ba4da8942","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315221031101/0001493152-21-031101-index.htm"}]}